CSL

Website: www.csl.com

CSL is a leading global biotechnology company, headquartered in Melbourne, Australia, with a portfolio of life-saving medicines, including those that treat haemophilia and immune deficiencies, as well as vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment. CSL focuses its world-class research and development, high-quality manufacturing, and patient-centered management to develop and deliver innovations to treat people with life-threatening medical conditions and help them live full lives.  Over the last five years CSL has invested more than USD$4 billion in research and development and employs more than 1,700 R&D experts globally.